开云app官网登录入口网页版-官方正版

#PureTech#

3篇内容 | 868人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1950288, encodeId=884319502883e, content=<a href='/topic/show?id=8dbe1489413' target=_blank style='color:#2F92EE;'>#PureTech#</a>, objectTitle=PureTech通过减少纤维化和炎症来治疗淋巴水肿的候选药LYT-100，其临床试验首位参与者开始接受治疗, objectType=article, longId=189496, objectId=66d91894967c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66d91894967c, replyNumber=0, likeNumber=61, createdTime=2020-04-20, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66d91894967c, moduleTitle=PureTech通过减少纤维化和炎症来治疗淋巴水肿的候选药LYT-100，其临床试验首位参与者开始接受治疗, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=66d91894967c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1950287, encodeId=2d89195028e9e, content=<a href='/topic/show?id=8dbe1489413' target=_blank style='color:#2F92EE;'>#PureTech#</a>, objectTitle=PureTech的新型口服制剂KarXT在治疗精神分裂症的II期临床中展现前景, objectType=article, longId=183284, objectId=b20218328463, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b20218328463, replyNumber=0, likeNumber=75, createdTime=2020-05-22, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b20218328463, moduleTitle=PureTech的新型口服制剂KarXT在治疗精神分裂症的II期临床中展现前景, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=b20218328463)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1950286, encodeId=a07319502863f, content=<a href='/topic/show?id=8dbe1489413' target=_blank style='color:#2F92EE;'>#PureTech#</a>, objectTitle=罗氏交易的消息提振了PureTech的股价, objectType=article, longId=144910, objectId=3643144910d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3643144910d1, replyNumber=0, likeNumber=62, createdTime=2019-01-28, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3643144910d1, moduleTitle=罗氏交易的消息提振了PureTech的股价, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=3643144910d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

PureTech

2020-05-29

minlingfeng (审核中...)

前往app查看评论内容

#PureTech#

PureTech通过减少纤维化和炎症来治疗淋巴水肿的候选药LYT-100，其临床试验首位参与者开始接受治疗

2020-04-20

minlingfeng (审核中...)

前往app查看评论内容

#PureTech#

PureTech的新型口服制剂KarXT在治疗精神分裂症的II期临床中展现前景

2020-05-22

minlingfeng (审核中...)

前往app查看评论内容

#PureTech#

罗氏交易的消息提振了PureTech的股价

2019-01-28

科室
- - 订阅+
  - 更多科室
工具
服务